0002088831-26-000002.txt : 20260821 0002088831-26-000002.hdr.sgml : 20260821 20260821122220 ACCESSION NUMBER: 0002088831-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260821 DATE AS OF CHANGE: 20260821 EFFECTIVENESS DATE: 20260821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kayak Therapeutics, Inc. CENTRAL INDEX KEY: 0002088831 ORGANIZATION NAME: EIN: 393869900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-585230 FILM NUMBER: 261303440 BUSINESS ADDRESS: STREET 1: 3317 BOWMAN AVENUE CITY: AUSTIN STATE: TX ZIP: 78703 BUSINESS PHONE: 917.892.9996 MAIL ADDRESS: STREET 1: 3317 BOWMAN AVENUE CITY: AUSTIN STATE: TX ZIP: 78703 D/A 1 primary_doc.xml X0708 D/A LIVE 0002088831 Kayak Therapeutics, Inc. 3317 BOWMAN AVENUE AUSTIN TX TEXAS 78703 917.892.9996 DELAWARE None None Corporation true 2025 Josiah Hornblower 3317 Bowman Avenue Austin TX TEXAS 78703 Executive Officer Director Tyler Brous 3317 Bowman Avenue Austin TX TEXAS 78703 Director Conor Richardson 3317 Bowman Avenue Austin TX TEXAS 78703 Executive Officer Taylor Schreiber 3317 Bowman Avenue Austin TX TEXAS 78703 Director Biotechnology Decline to Disclose 06b true 0002088831-26-000001 2026-05-12 false true false 0 30000000 24981000 5019000 false 137 0 0 0 false Kayak Therapeutics, Inc. Conor Richardson Conor Richardson Chief Financial Officer 2026-08-21